Table 1.
Regimen (Source) | Total No. of Doses | Days of Coverage | Date of First Dose | Interval, d | |
---|---|---|---|---|---|
Between Doses 1 and 2 | After Dose 2 | ||||
Seasonal (Pickering et al,11 2014) | 5 | 159 | Onset of local RSV season | 30 | 30 |
NOV1 (Pickering et al,11 2014) | 5 | 159 | Nov 1 | 30 | 30 |
MED30 (Panozzo et al,17 2010) | 5 | 159 | 30 d before onset of 5 past local seasons | 30 | 30 |
OFS (present study) | 5 | 181 | Optimized to local RSV dataa | 29 | 38 |
OFS4 (present study) | 4 | 143 | |||
OFS3 (present study) | 3 | 105 |
Abbreviations: MED30, initiates injections 30 days before the median start date across the 5 most recent RSV seasons; NOV1, recommends the first injection occur on November 1; OFS, optimized fixed start; OFS3, 3-injection OFS; OFS4, 4-injection OFS; RSV, respiratory syncytial virus.
Injections are timed so to achieve protective concentrations of palivizumab on days of the year when the hospitalization rate is the highest based on local data from previous seasons.